386 related articles for article (PubMed ID: 18506897)
1. Coordinate regulation of gallbladder motor function in the gut-liver axis.
Portincasa P; Di Ciaula A; Wang HH; Palasciano G; van Erpecum KJ; Moschetta A; Wang DQ
Hepatology; 2008 Jun; 47(6):2112-26. PubMed ID: 18506897
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol gallstone disease.
Portincasa P; Moschetta A; Palasciano G
Lancet; 2006 Jul; 368(9531):230-9. PubMed ID: 16844493
[TBL] [Abstract][Full Text] [Related]
3. [Role of biliary proteins in pathogenesis of cholesterol gallstones].
Secknus R; Holzbach RT
Z Gastroenterol; 1997 Jan; 35(1):41-6. PubMed ID: 9123957
[TBL] [Abstract][Full Text] [Related]
4. The role of the gallbladder in the pathogenesis of cholesterol gallstones.
LaMorte WW; Schoetz DJ; Birkett DH; Williams LF
Gastroenterology; 1979 Sep; 77(3):580-92. PubMed ID: 456853
[TBL] [Abstract][Full Text] [Related]
5. Pathobiology of cholesterol gallstone disease: from equilibrium ternary phase diagram to agents preventing cholesterol crystallization and stone formation.
Portincasa P; Moschetta A; Calamita G; Margari A; Palasciano G
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Mar; 3(1):67-81. PubMed ID: 12570727
[TBL] [Abstract][Full Text] [Related]
6. Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults.
Portincasa P; Moschetta A; Berardino M; Di-Ciaula A; Vacca M; Baldassarre G; Pietrapertosa A; Cammarota R; Tannoia N; Palasciano G
World J Gastroenterol; 2004 Aug; 10(16):2383-90. PubMed ID: 15285024
[TBL] [Abstract][Full Text] [Related]
7. Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.
Wang HH; Portincasa P; Wang DQ
Curr Med Chem; 2019; 26(19):3407-3423. PubMed ID: 28625150
[TBL] [Abstract][Full Text] [Related]
8. Relation of gallbladder motility to viscosity and composition of gallbladder bile in patients with cholesterol gallstones.
Gründel D; Jüngst C; Straub G; Althaus R; Schneider B; Spelsberg FW; Hüttl TP; del Pozo R; Jüngst D; Neubrand M
Digestion; 2009; 79(4):229-34. PubMed ID: 19390195
[TBL] [Abstract][Full Text] [Related]
9. Gallbladder function in gallstone disease.
Everson GT
Gastroenterol Clin North Am; 1991 Mar; 20(1):85-110. PubMed ID: 2022427
[TBL] [Abstract][Full Text] [Related]
10. Intestinal aspects of cholesterol gallstone formation.
van Erpecum KJ; van Berge Henegouwen GP
Dig Liver Dis; 2003 Jul; 35 Suppl 3():S8-11. PubMed ID: 12974502
[TBL] [Abstract][Full Text] [Related]
11. Gallstone disease.
Marschall HU; Einarsson C
J Intern Med; 2007 Jun; 261(6):529-42. PubMed ID: 17547709
[TBL] [Abstract][Full Text] [Related]
12. [An investigation of the relationship of gallbladder motility and gallstone formation in patients with liver cirrhosis].
Hao RR; Wang HJ; Jia JD; Li CL
Zhonghua Gan Zang Bing Za Zhi; 2006 Feb; 14(2):137-8. PubMed ID: 16494788
[No Abstract] [Full Text] [Related]
13. From lipid secretion to cholesterol crystallization in bile. Relevance in cholesterol gallstone disease.
Portincasa P; Moschetta A; Palasciano G
Ann Hepatol; 2002; 1(3):121-8. PubMed ID: 15280810
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.
Jüngst C; Sreejayan N; Zündt B; Müller I; Spelsberg FW; Hüttl TP; Kullak-Ublick GA; del Pozo R; Jüngst D; von Ritter C
Eur J Clin Invest; 2008 Sep; 38(9):634-9. PubMed ID: 18837739
[TBL] [Abstract][Full Text] [Related]
15. [Changes of gastrointestinal myoelectric activity and bile acid pool during cholesterol gallstone formation in guinea pigs].
Zhang XM; Dong L; Liu LN
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1251-5, 1260. PubMed ID: 16234101
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the functional state of the biliary tract by dynamic echocholecystography].
Dynnik OB
Fiziol Zh (1978); 1990; 36(2):63-7. PubMed ID: 2193832
[TBL] [Abstract][Full Text] [Related]
17. [Significance of the gallbladder in the regulation of duodenogastric reflux].
Wechsler JG
Z Gastroenterol; 1987 Aug; 25 Suppl 3():15-21. PubMed ID: 3310429
[TBL] [Abstract][Full Text] [Related]
18. [Gallbladder disease and obesity].
Méndez-Sánchez N; Chávez-Tapia NC; Uribe M
Gac Med Mex; 2004; 140 Suppl 2():S59-66. PubMed ID: 15641473
[TBL] [Abstract][Full Text] [Related]
19. Drugs affecting biliary lipid secretion and gallbladder motility: their potential role in gallstone treatment and prevention.
vanBerge-Henegouwen GP; Venneman NG; van Erpecum KJ; Portincasa P
Curr Drug Targets Immune Endocr Metabol Disord; 2005 Jun; 5(2):185-91. PubMed ID: 16089351
[TBL] [Abstract][Full Text] [Related]
20. Natural history of small gallbladder polyps is benign: evidence from a clinical and pathogenetic study.
Colecchia A; Larocca A; Scaioli E; Bacchi-Reggiani ML; Di Biase AR; Azzaroli F; Gualandi R; Simoni P; Vestito A; Festi D
Am J Gastroenterol; 2009 Mar; 104(3):624-9. PubMed ID: 19209165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
